RIGL earnings
Rigel Pharmaceuticals (RIGL) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
RIGL earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | 0.88 | 0.09 | 903.88% | $78.70M |
| Q1 2026 | May 5, 2026 | 0.44 | 0.74 | -40.54% | $58.82M |
| Q4 2025 | Mar 3, 2026 | 1.14 | 1.33 | -14.29% | $69.80M |
| Q3 2025 | Nov 4, 2025 | 1.46 | 0.93 | 56.99% | $69.46M |
| Q2 2025 | Aug 5, 2025 | 3.28 | 1.97 | 66.50% | $101.69M |
| Q1 2025 | May 6, 2025 | 0.63 | 0.14 | 350.00% | $53.33M |
| Q4 2024 | Mar 4, 2025 | 0.80 | 0.30 | 166.67% | $57.60M |
| Q3 2024 | Nov 7, 2024 | 0.70 | 0.06 | 1066.67% | $55.31M |
| Q2 2024 | Aug 6, 2024 | -0.06 | -0.37 | 83.78% | $36.84M |
| Q1 2024 | May 7, 2024 | -0.50 | -0.30 | -66.67% | $29.53M |
| Q4 2023 | Mar 5, 2024 | 0.04 | 0.02 | 100.00% | $35.79M |
| Q3 2023 | Nov 7, 2023 | -0.30 | -0.70 | 57.14% | $28.13M |
| Aug 1, 2023 | -0.40 | -0.80 | 50.00% | – | |
| May 2, 2023 | -0.80 | -0.90 | 11.11% | – | |
| Mar 7, 2023 | 0.10 | -0.70 | 114.29% | – | |
| Nov 3, 2022 | -1.10 | -1.30 | 15.38% | – | |
| Aug 2, 2022 | -0.80 | -1.20 | 33.33% | – | |
| May 3, 2022 | -1.60 | -0.14 | -1042.86% | – | |
| Mar 1, 2022 | -1.30 | -1.30 | 0.00% | – | |
| Nov 2, 2021 | -1.20 | -1.00 | -20.00% | – |
- RIGL reports next on Nov 5, 2026, with EPS of 0.85 expected.
- RIGL beat EPS estimates in 64 of its last 100 reports.
Updated 2026-11-05 12:51 UTC